Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Barrett Esophagus 6Stomach Neoplasms 4Gastritis 3Zollinger-Ellison Syndrome 2Stomach Ulcer 2Peptic Ulcer 2Esophageal Neoplasms 2Dyspepsia 2Colorectal Neoplasms 2Breast Neoplasms 2Precancerous Conditions 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Hot Flashes 1Hemorrhage 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastroesophageal Reflux 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Esophagitis, Peptic 1Colonic Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Nivolumab 2rofecoxib 1paclitaxel poliglumex 1nazartinib 1atezolizumab 1Rosuvastatin Calcium 1RO5126766 1Pemetrexed 1Midazolam 1Gemcitabine 1Food 1Esomeprazole 1Dabigatran 1Cisplatin 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Non-small Cell Lung Cancer × Esomeprazole × Clear all
NCT06378658 2024-07-05

A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants

Bayer

Phase 1 Completed
21 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡